ROLE OF A PHARMACIST IN PREVENTION AND DETECTION OF OTC DRUG INTERACTIONS: NOMINAL GROUP TECHNIQUE
Abstract
Introduction: Nowadays number of newly approved OTC medicines continuously increases, which can make certain difficulties in drug dispensing process. This fact particularly relates to drug-drug interactions - problems due to lack of data and insufficient of knowledge about the interactions.
Aim: To identify the problems pharmacists face when dispensing OTC drugs and to recommend concrete ideas and methods for improving system for detecting OTC drugs interactions.
Participants and method: The study was carried out in accordance with methodological principles of nominal group technique. Two meetings of nominal group were conducted, enrolling pharmacists employed in public pharmacies. During the meetings, moderator imposed a set of questions to participants, who gave answers in the form of individual statements. In order to examine agreement of the participants about the individual statements, at the end of both sessions the statements were rated on a Likert’s scale. Meetings were recorded and audio recordings later used for qualitative analysis.
Results: Nine pharmacists of both sex (7/2 females/males) participated in this study. Average age of the participants was 25.0±1.0 years. During nominal group meetings, participants presented 30 statements on 7 research questions, and after the second meeting agreement was reached about 29 of them. Qualitative analysis of data indicated three categories of statements: (1) pharmacists’ knowledge of OTC drugs interactions, (2) problems pharmacists face when dispensing OTC drugs and (3) options of improving system for prevention and detection of OTC drugs interactions.
Conclusion: For adequate prevention of potential OTC drugs interactions it is necessary to make guidelines with recommendations referring to proper dispensing procedure and to use regularly available online interaction checkers.References
Gavronski M, Volmer D. Safety concerns in simulta-neous use of prescription and 'over-the-counter' medi-cines- results of patient survey in Estonia. Springerplus 2014;3:143.
Schmiedl S, Rottenkolber M, Hasford J, et al. Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admis-sions: results of a prospective, long-term multi-centre study. Drug Saf 2014;37(4):225-35.
Eickhoff C, Hämmerlein A, Griese N, Schulz M. Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany. Pharmacoepidemiol Drug Saf 2012;21(3):254-60.
Calamusa A, Di Marzio A, Cristofani R, et al. Factors that influence Italian consumers' understanding of over-the-counter medicines and risk perception. Patient Educ Couns 2012;87(3):395-401.
Nomura K, Kitagawa Y, Yuda Y, Takano-Ohmuro H. Medicine reclassification processes and regulations for proper use of over-the-counter self-care medicines in Japan. Risk Manag Healthc Policy 2016;9:173-83.
Albert SM, Bix L, Bridgeman MM, et al. Promoting safe and effective use of OTC medications: CHPA-GSA National Summit. Gerontologist 2014;54(6):909-18.
Javna agencija Republike Slovenije za zdravila in medi-cinske pripomočke. Podatkio zdravilih in medicinskih pripomočkih. Centralna baza zdravil. Посећено у септембру 2017. године на: http://www.cbz.si/cbz/bazazdr2.nsf/Search?SearchView&Query=(%5BSIREZIZD%5D=17)&SearchOrder=4&SearchMax=301.
Langley PC. The prevalence, correlates and treatment of pain in the European Union. Curr Med Res Opin 2011;27(2):463-80.
Kloosterboer SM, McGuire T, Deckx L, Moses G, Ver-heij T, van Driel ML. Self-medication for cough and the common cold: information needs of consumers. Aust Fam Physician 2015;44(7):497-501.
Bond C, Hannaford P. Issues related to monitoring the safety of over-the-counter (OTC) medicines. Drug Saf 2003;26(15):10674.
Wróblewski T, Kobryń K, Kozieł S, et al. Acetaminop-hen (Paracetamol) induced acute liver failure - A social problem in an era of increasing tendency to self-treat-ment. Ann Agric Environ Med 2015;22(4):762-7667.
Ogawa R, Echizen H. Clinically significant drug intera-ctions with antacids: an update. Drugs 2011;71(14):1839-64.
Moore N, Pollack C, Butkerait P. Adverse drug reac-tions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag 2015;11:1061-75.
Dimitrijević M, Djordjević-Catić A, Stefanović N, Pav-lović D, Veličković-Radovanović R. Self-medication in primary healthcare in the territory of the city of Niš. Acta Medica Medianae 2014; 53(3):19-24.
Schillemans S, De Loof H, De Meyer GR. [Critical eva-luation of interaction screening software available in pharmacies]. J Pharm Belg 2012;(4):4-13.
Pedersen M, Brabrand M. One fourth of acutely admit-ted patients use over-the-counter-drugs 24 hours prior to hospitalisation. Dan Med J 2014;61(2):A4789.
Klemenc-Ketis Z, Kersnik J. Sources and predictors of home-kept prescription drugs. Int J Clin Pharmacol Ther 2010;48(11):705-7.
Gallagher M, Hares T, Spencer J, Bradshaw C, Webb I. The nominal grouptechnique: a research tool for general practice? Fam Pract 1993 Mar;10(1):76-81.
Janković SM. Struktura dizajna (plana) istraživanja. In: Janković SM. Dizajn istraživanja. 1st ed. Kragujevac: Medicinsko društvo za racionalnu terapiju Republike Srbije – Medrat, 2016: 129-32.
Veiga P, Lapão LV, Cavaco AM, Guerreiro MP. Quality supply of nonprescription medicines in Portu-guese community pharmacy: An exploratory case study. Res Social Adm Pharm 2015;11(6):880-90.
Raynor DK, Dickinson R, Knapp P, Long AF, Nicolson DJ. Buyer beware? Does the information provided with herbal products available over the counter enable safe use? BMC Med 2011;9:94.
Halila GC, Junior EH, Otuki MF, Correr CJ. The practi-ce of OTC counseling by community pharmacists in Parana, Brazil. Pharmacy Practice 2015;13(4):597.
Shilbayeh SA. Exploring knowledge and attitudes towards counselling about vitamin supplements in Jor-danian community pharmacies. Pharm Pract (Granada) 2011;9(4):242-51.
Atayee RS, Singh RF, Best BM, Freedman BA, Morello CM. An active-learning assignment involving peer-to-peer presentations to improve pharmacy stu-dents' attitudes and knowledge of dietary supplements. Am J Pharm Educ 2012;76(6):113.
Kwan D, Boon HS, Hirschkorn K, et al. Exploring con-sumer and pharmacist views on the professional role of the pharmacist with respect to natural health products: a study of focus groups. BMC Complement Altern Med 2008;8:40.
Scarton LA, Del Fiol G, Treitler-Zeng Q. Completeness, accuracy, and presentation of information on interactions between prescription drugs and alternative medicines: an internet review. Stud Health Technol Inform 2013;192:841-5.
Faerber AE, Kreling DH. Content analysis of false and misleading claims in television advertising for pre-scription and nonprescription drugs. J Gen Intern Med 2014;29(1):110-8.
Gastelurrutia MA, Benrimoj SI, Castrillon CC, de Ame-zua MJ, Fernandez-Llimos F, Faus MJ. Facilitators for practice change in Spanish community pharmacy. Pharm World Sci 2009;31(1):32-9.
Kooy MJ, Dessing WS, Kroodsma EF, et al. Frequency, nature and determinants of pharmaceutical consultations provided in private by Dutch community pharmacists. Pharm World Sci 2007;29(2):81-9.
Garrard J, Harms S, Eberly LE, Matiak A. Variations in product choices of frequently purchased herbs: caveat emptor. Arch Intern Med 2003;163:2290–2295.
Hämmerlein A, Griese N, Schulz M. Survey of drug-related problems identifiedby community pharmacies. Ann Pharmacother 2007;41(11):1825-32.
Day RO, Snowden L. Where to find information about drugs. Aust Prescr 2016;39(3):88-95.
Thomson Reuters (Healthcare) Inc. MICROMEDEX Gateway. Посећено у мају 2017. године на: www.thomsonhc.com/home/dispatch.
Epocrates, Inc. Interaction Checker. Посећено у мају 2017. године на: https://online.epocrates.com/ interaction-check.
Medscape. Multi-Drug Interaction checker. Посећено у мају 2017. године на: http://reference.medscape.com/drug-interactionchecker.